Company news
Oncology Pharma Inc. news in 2022
Oncology Pharma Inc.'s news releases, calls and decks from 2022, newest first.
Oncology Pharma Conducting Interviews and Presentations with Investors to Pursue Next Steps to Forward The Development Process of Nanoemulsion Drug Delivery System
July 11, 2022
Oncology Pharma Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery System
June 28, 2022
Oncology Pharma Announces: Initial Feasibility Study of the Nanoemulsion Drug Delivery System is Complete and Results Have Met the Threshold for Moving Forward To the Next Steps of Development
June 7, 2022
Oncology Pharma Advances Progress on Multiple Fronts Including Advanced Attention to Connect2Trials' Commercial Development
May 8, 2022
Oncology Pharma Completes Feasibility Phase of its Licensed Nanoemulsion Drug Delivery System to Treat Cancer
April 12, 2022
Oncology Pharma Reports on Progress with Ribera Solutions
March 1, 2022
Oncology Pharma Releases Further Feasibility Studies, Data and Capacities
February 22, 2022
Oncology Pharma Expands on Feasibility Studies and Data
February 16, 2022
Oncology Pharma, Inc. and Regen BioPharma, Inc. Announce Intent to Jointly Fast Track Development of Modified mRNA anti-Cancer Vaccine
February 13, 2022
Oncology Pharma Gives Update on Technology, Formulation and Data Creation
February 7, 2022
Oncology Pharma's New Year Update
January 9, 2022